Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma.

Lin, Min; Kowolik, Claudia M; Xie, Jun; Yadav, Sushma; Overman, Larry E; Horne, David A

Lin, Min; Kowolik, Claudia M; Xie, Jun; Yadav, Sushma; Overman, Larry E; Horne, David A.

Afiliación

Lin M; Department of Molecular Medicine, City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA 91010, USA.
Kowolik CM; Department of Molecular Medicine, City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA 91010, USA.
Xie J; Department of Molecular Medicine, City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA 91010, USA.
Yadav S; Department of Molecular Medicine, City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA 91010, USA.
Overman LE; Department of Translational Research and Cellular Therapeutics, City of Hope National Medical Center, 1500 E. Duarte Road, Duarte, CA 91010, USA.
Horne DA; Department of Chemistry, University of California, Irvine, CA 92697-2025, USA.

Cancers (Basel) ; 13(13)2021 Jul 05.

Article en En | MEDLINE | ID: mdl-34282785

Palabras clave

GLI1; NT1721; STAT3; cutaneous T cell lymphoma (CTCL); epidithiodiketopiperazine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google